Our study days are sponsored by pharmaceutical companies, who provide funding that allows us to offer all events completely free of charge. Sponsors have no involvement in agenda development, speaker selection, or clinical content – this is managed entirely by MORPh’s clinical team.
The “Multi-topic study day: Blood Test Interpretations and Excellence in Respiratory Care” Study Day is free to access for all registered healthcare professionals that have a MORPh Account.
Doors will open at 09:00 for welcome and introductions the study day will begin shortly after. Our expert speakers will be discussing the following topics:
Learning Objectives:Â
- Interpret common blood test patterns in primary care, including FBC, renal, liver, thyroid, bone profile, lipids, and haematinics, to support clinical decision-makingÂ
- Identify medicines optimisation triggers from blood results, including when to review, adjust, or stop high-risk medicinesÂ
- Recognise red flags and abnormal patterns requiring further investigation, monitoring, or referralÂ
- Apply updated asthma guidance in primary care reviews, including diagnosis, medication optimisation, and effective patient consultationsÂ
Blood Test Interpretation in Primary Care
- FBC patterns that matter in primary care (anaemia types, infection markers, platelets) and when to escalate.
- U&Es/eGFR: recognising AKI vs CKD and acting on K+/Na+ abnormalities.
- Medicines optimisation triggers: ACEi/ARB, diuretics, NSAIDs, metformin, lithium, digoxin. What to stop/hold/review.
- LFT patterns (hepatocellular vs cholestatic): when to repeat, stop, or investigate.Â
Blood Tests That Drive Decisions: Bone Profile, TFTs, Lipids and Haematinics
- Bone profile: calcium/ALP patterns, vitamin D clues, hypercalcaemia red flags.
- TFTs: subclinical vs overt disease; levothyroxine adjustment and interaction/absorption issues.
- Lipids: using non-HDL/CV risk to guide statin decisions and follow-up.
- Haematinics: iron deficiency vs chronic disease; B12/folate patterns and referral triggers.Â
Asthma & COPD in Primary Care: Clinical Updates – CPD Accredited

- Apply validated tools and clinical criteria to identify poorly controlled asthma and high-risk patients, including recognition of SABA overuse patterns Â
- Demonstrate a structured approach to consulting with a patient with poorly controlled asthma and SABA overuse, including behaviour change concepts and co-producing a personalised asthma action planÂ
- Summarise key updates from GOLD guidelines and identify the pharmacological and non-pharmacological management priorities in primary careÂ
- Apply a step-wise optimisation approach to a COPD patient’s plan to help reduce exacerbations and admission riskÂ
- Assess a rescue pack request in COPD, deliver person-centred counselling on exacerbation recognition, treatment, safety netting and when to escalateÂ